|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
25,750,000 |
Market
Cap: |
1.14(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$8.1 - $45.33 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 12.9 |
Insider 3/6 Months : 13.5 |
|
Guru Rank Number : 232 |
Guru Rank Value : 6.7 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Harrow Health engages in the development, production and sale of medications. Co. owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical businesses. Through its subsidiaries, Visionology, Inc., which provides an online eye health platform; Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
119,400 |
211,500 |
699,568 |
Total Buy Value |
$0 |
$1,355,431 |
$2,209,591 |
$7,583,356 |
Total People Bought |
0 |
1 |
2 |
3 |
Total Buy Transactions |
0 |
5 |
9 |
15 |
Total Shares Sold |
0 |
0 |
0 |
40,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$504,800 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kammer Robert J |
Director |
|
2015-04-23 |
4 |
OE |
$5.93 |
$90,546 |
D/D |
15,282 |
988,546 |
|
- |
|
Boll Andrew |
Chief Financial Officer |
|
2015-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
187,500 |
187,500 |
|
- |
|
Saharek John P. |
Chief Commercial Officer |
|
2015-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
Kammer Robert J |
Director |
|
2014-09-30 |
4 |
D |
$7.42 |
$323,438 |
D/D |
(43,590) |
973,264 |
|
- |
|
Kammer Robert J |
Director |
|
2014-09-30 |
4 |
OE |
$4.50 |
$323,438 |
D/D |
71,875 |
1,001,692 |
|
- |
|
Bassani August Shelby |
Director |
|
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
13,488 |
|
- |
|
Kammer Robert J |
Director |
|
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
944,979 |
|
- |
|
Austin Stephen G |
Director |
|
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
13,488 |
|
- |
|
Nelson William H. |
Director |
|
2014-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,623 |
6,623 |
|
- |
|
134 Records found
|
|
Page 6 of 6 |
|
|